SPARK-ALL: Calaspargase Pegol in Adults With ALL

Clinical trial NCT04817761 · TERMINATED

Trial details

NCT number: NCT04817761
Sponsor: Institut de Recherches Internationales Servier
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia

Start date: 2021-07-07
Primary completion: 2025-03-21
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.